Table 3.
MBTTS | RVPAS | P Value | |
---|---|---|---|
Total costs | |||
1 y, n = 107 (72%), 114 (74%) | $656,004 ± 331,984 | $776,547 ± 556,160 | 0.05 |
3 y, n = 95 (64%), 95 (62%) | $875,549 ± 623,776 | $972,656 ± 926,326 | 0.40 |
5 y, n = 56 (38%), 66 (43%) | $1,209,790 ± 1,092,009 | $1,290,784 ± 1,241,318 | 0.71 |
Total daily costs | |||
1 y, n = 107 (72%), 114 (74%) | $1,796 ± 909 | $2,126 ± 1,523 | 0.05 |
3 y, n = 95 (64%), 95 (62%) | $799 ± 569 | 888 ± 845 | 0.40 |
5 y, n = 56 (38%), 66 (43%) | $662 ± 598 | 707 ± 680 | 0.71 |
Values are mean ± SD in US$.
For each time period, the number of participants and the percentage of the total cohort are listed.
MBTTS = modified Blalock-Taussig-Thomas shunts; RVPAS = right ventricle to pulmonary artery shunts.